Brefeldin A
WikiDoc Resources for Brefeldin A |
Articles |
---|
Most recent articles on Brefeldin A Most cited articles on Brefeldin A |
Media |
Powerpoint slides on Brefeldin A |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Brefeldin A at Clinical Trials.gov Clinical Trials on Brefeldin A at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Brefeldin A
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Brefeldin A Discussion groups on Brefeldin A Patient Handouts on Brefeldin A Directions to Hospitals Treating Brefeldin A Risk calculators and risk factors for Brefeldin A
|
Healthcare Provider Resources |
Causes & Risk Factors for Brefeldin A |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Brefeldin A is a lactone antibiotic produced by fungal organisms such as Eupenicillium brefeldianum. Brefeldin A interferes with anterograde protein transport from the endoplasmic reticulum to the Golgi apparatus by inhibiting transport in Golgi, which leads to proteins accumulating inside the ER. In mammalian and yeast cells, the main target of brefeldin A appears to be a certain type of GTP-exchange factors responsible for activating a GTPase called Arf1p ; in turn, Arf1p is involved in the formation of transport vesicles by recruiting coat proteins to intracellular membranes. Brefeldin A was initially isolated as an anti-viral antibiotic [1] but is now primarily used in biological research to study protein transport.
Physical data
- Appearance: White to off-white crystalline powder
- Solubility: Clear colorless solution at 10mg/ml Dichloromethane.
- Clear colorless solution at 10mg/ml Methanol.
- Melting point: 297°C-205°C
Brefeldin A affects COPI coat formation, which is involved in retrograde transport. It inhibits ArfI activation, prohibiting recruitment of COPI coat proteins to the budding vessicle by binding to its guanine exchange factor.
External links
- Brefeldin A: insights into the control of membrane traffic and organelle structure. (Review, 1992)
- Brefeldin A: Deciphering an Enigmatic Inhibitor of Secretion. (Review, 2002)